BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2017
View Archived Issues
DUSP1 identified as a therapeutic target for pulmonary fibrotic diseases
Read More
Ionis Pharmaceuticals' Spinraza approved in E.U. for spinal muscular atrophy
Read More
Eleven Biotherapeutics cleared to continue phase III study of Vicinium
Read More
Achaogen begins clinical development program of C-Scape
Read More
Novel missense mutation in PLEC gene tied to atrial fibrillation
Read More
Genentech files regulatory submissions to begin phase I studies of BL-8040 plus atezolizumab
Read More
Inovio Pharmaceuticals enters immuno-oncology collaboration with Genentech
Read More
Targeting CD98 shrinks malignant mesothelioma tumors in vivo
Read More
Orexo receives milestone payment triggered by OX-CLI phase I initiation
Read More
The University of Florida and Torrey Pines Institute patent alpha-enolase inhibitors
Read More
The University of Rochester presents bortezomib conjugates
Read More
Reata reports data from part 1 of phase II MOXIe trial of omaveloxolone in Friedreich's ataxia
Read More
Incyte identifies PI3Kgamma inhibitors
Read More
Voyager Therapeutics selects Huntington's disease clinical candidate
Read More
Mirati Therapeutics divulges LSD1 inhibitors
Read More
Biomarin Pharmaceutical wins E.U. approval of Brineura for CLN2
Read More
Thetis Pharmaceuticals discloses amino acid salts of saturated fatty acids
Read More
Deciphera closes series C financing to support development of oncology products
Read More
Vaxon Biotech reports results from phase IIb study of VX-001 cancer vaccine
Read More
Novel pyrazolopyridine KDU-731 a candidate for treating cryptosporidiosis
Read More
Ligand Pharmaceuticals, Surface Oncology enter OmniAb license agreement
Read More
U.S. and E.U. submissions made for dolutegravir/rilpivirine single-tablet regimen for HIV-1
Read More
DOCK6 gene found to be involved in ciliopathies
Read More
GHIT Fund secures over USD 200 million in commitments for second phase replenishment
Read More
FDA approves Roche's companion diagnostic for Zykadia
Read More